Gene · 51135
Papers3,419
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,419
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Efficacy and Safety of Zabedosertib, an Interleukin-1 Receptor-Associated Kinase 4 Inhibitor, in Patients with Moderate-to-Severe Atopic Dermatitis: A Phase II Randomized Study. | Dermatol Ther (Heidelb) | 2025 | 40906353 | PubTator, text mining | PubMed |
| Targeted protein degradation in autoimmune diseases: from mechanisms to therapeutic breakthroughs. | J Autoimmun | 2025 | 40902463 | PubTator, text mining | PubMed |
| Bladder Cancer: Role of Circular RNAs in Oncogenesis, Tumor Suppression, and Therapeutic Target Identification. | Cancer Genomics Proteomics | 2025 | 40883021 | PubTator, text mining | PubMed |
| T cell exhaustion‑related gene CD79B predicts prognosis, inhibits malignant progression and promotes tumor‑associated macrophage M1‑like polarization in lung adenocarcinoma. | Oncol Rep | 2025 | 40878933 | PubTator, text mining | PubMed |
| In vivo mechanisms of resveratrol liposomes in targeting the TLR4/NLRP3 pathway in lung cancer. | Sci Rep | 2025 | 40877308 | PubTator, text mining | PubMed |
| Harnessing free energy calculations for kinome-wide selectivity in drug discovery campaigns with a Wee1 case study. | Nat Commun | 2025 | 40858617 | PubTator, text mining | PubMed |
| Study on differentially expressed genes and pattern recognition receptors in osteoporosis based on bioinformatics analysis. | Sci Rep | 2025 | 40854963 | PubTator, text mining | PubMed |
| Discovery of GLPG4471, a potent and selective IRAK4 inhibitor for the treatment of inflammatory and autoimmune diseases. | Bioorg Med Chem Lett | 2025 | 40854432 | PubTator, text mining | PubMed |
| Mechanism and cellular actions of the potent AMPK inhibitor BAY-3827. | Sci Adv | 2025 | 40845097 | PubTator, text mining | PubMed |
| Inflammatory signaling in the pathogenesis of acute myeloid leukemia. | Hemasphere | 2025 | 40809350 | PubTator, text mining | PubMed |
| Comprehensive view on chemotherapy-free management of acute myeloid leukemia by using venetoclax in combination with targeted and/or immune therapies. | Cell Death Discov | 2025 | 40804253 | PubTator, text mining | PubMed |
| Immunologic profiling of the infant immune response to whole-cell and acellular pertussis vaccines. | NPJ Vaccines | 2025 | 40790123 | PubTator, text mining | PubMed |
| Optimization of IRAK1/4/pan-FLT3 kinase inhibitors as treatments for acute myeloid leukemia. | Bioorg Med Chem Lett | 2025 | 40754220 | PubTator, text mining | PubMed |
| The impact of sarcopenia on prognosis and fruquintinib efficacy in advanced colorectal cancer: a retrospective and mendelian randomization study. | Front Immunol | 2025 | 40740773 | PubTator, text mining | PubMed |
| Synthesis, biological evaluation and clinical trials of Cereblon-based PROTACs. | Commun Chem | 2025 | 40730655 | PubTator, text mining | PubMed |
| Modulation of IRAK4 as a Therapeutic Strategy Against Monosodium Urate- and Xanthine-Induced Inflammation in Macrophages and HepG2 Cells. | Res Sq | 2025 | 40709261 | PubTator, text mining | PubMed |
| Targeting of IRAK4 and GSPT1 enhances therapeutic efficacy in AML via c-Myc destabilization. | Leukemia | 2025 | 40670672 | PubTator, text mining | PubMed |
| Shared and disease-specific pathways in frontotemporal dementia and Alzheimer's and Parkinson's diseases. | Nat Med | 2025 | 40665052 | PubTator, text mining | PubMed |
| Genetic adaptations of innate immune genes in Tibetans: Insights into protection against pulmonary hypertension and hepatitis B virus infection in high-altitude environments. | Genomics | 2025 | 40659224 | PubTator, text mining | PubMed |
| Meeting Report From the 2024 Symposium on IRAK4 in Cancer: Highlights and Clinical Updates. | Clin Lymphoma Myeloma Leuk | 2025 | 40634180 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51135/papers?page=5